Kura Oncology, Inc. Forecast, price target & analysts
Kura Oncology, Inc. Target price 2026 - Analyst rating & recommendation
Kura Oncology, Inc. Classifications & Recommendation
Kura Oncology, Inc. Price Target
| Target Price | $28.56 |
| Price | $11.72 |
| Potential |
143.69%
register free of charge
|
| Number of Estimates | 14 |
|
14 Analysts have issued a price target Kura Oncology, Inc. 2027 .
The average Kura Oncology, Inc. target price is $28.56.
This is
143.69%
register free of charge
$79.80
580.89%
register free of charge
$15.15
29.27%
register free of charge
|
|
| A rating was issued by 22 analysts: 19 Analysts recommend Kura Oncology, Inc. to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Kura Oncology, Inc. stock has an average upside potential 2027 of
143.69%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 67.48 | 94.78 |
| 25.24% | 40.46% | |
| EBITDA Margin | -448.43% | -342.63% |
| 25.61% | 23.59% | |
| Net Margin | -412.97% | -312.19% |
| 27.89% | 24.40% |
18 Analysts have issued a sales forecast Kura Oncology, Inc. 2026 . The average Kura Oncology, Inc. sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Kura Oncology, Inc. EBITDA forecast 2026. The average Kura Oncology, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
17 Kura Oncology, Inc. Analysts have issued a net profit forecast 2026. The average Kura Oncology, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -3.18 | -3.33 |
| 57.43% | 4.72% | |
| P/E | negative | |
| EV/Sales | 5.67 |
17 Analysts have issued a Kura Oncology, Inc. forecast for earnings per share. The average Kura Oncology, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Kura Oncology, Inc....
Current Kura Oncology, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Citizens |
Locked
➜
Locked
|
Locked | Aug 24 2026 |
| Wedbush |
Locked
➜
Locked
|
Locked | Aug 13 2026 |
| Wedbush |
Locked
➜
Locked
|
Locked | Jul 28 2026 |
| Citizens |
Locked
➜
Locked
|
Locked | Jun 15 2026 |
| Lake Street |
Locked
➜
Locked
|
Locked | Apr 14 2026 |
| Mizuho |
Locked
➜
Locked
|
Locked | Mar 24 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Mar 13 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Citizens:
Locked
➜
Locked
|
Aug 24 2026 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Aug 13 2026 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Jul 28 2026 |
|
Locked
Citizens:
Locked
➜
Locked
|
Jun 15 2026 |
|
Locked
Lake Street:
Locked
➜
Locked
|
Apr 14 2026 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Mar 24 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Mar 13 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
